Trial Outcomes & Findings for Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece (NCT NCT01282866)
NCT ID: NCT01282866
Last Updated: 2016-10-21
Results Overview
The hair at the treatment area is counted at Baseline and 6 months following the last treatment. Hair clearance is determined by the percentage of Hair left 6 months following the last treatment compared to the hair number at baseline.
COMPLETED
NA
35 participants
6 month following last treatment
2016-10-21
Participant Flow
Participant milestones
| Measure |
HS Treatment
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm\^2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Overall Study
STARTED
|
35
|
|
Overall Study
COMPLETED
|
34
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
HS Treatment
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm\^2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Overall Study
Adverse Event
|
1
|
Baseline Characteristics
Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece
Baseline characteristics by cohort
| Measure |
HS Treatment
n=35 Participants
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm\^2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Age, Continuous
|
30.9 years
STANDARD_DEVIATION 10 • n=5 Participants
|
|
Sex: Female, Male
Female
|
35 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
35 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 month following last treatmentThe hair at the treatment area is counted at Baseline and 6 months following the last treatment. Hair clearance is determined by the percentage of Hair left 6 months following the last treatment compared to the hair number at baseline.
Outcome measures
| Measure |
HS Treatment
n=34 Participants
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Hair Count
|
54 percentage of hair clearance
Standard Deviation 24
|
SECONDARY outcome
Timeframe: Each treatmentThe treatment time was measured for each participant on each and every visit. The result is presented as mean of all treatment time from all of the visits and all of the participants.
Outcome measures
| Measure |
HS Treatment
n=34 Participants
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Treatment Time
|
3.5 minutes
Standard Deviation 2.7
|
SECONDARY outcome
Timeframe: Each treatmentOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 15 month following last treatmentPopulation: The number of participants who completed 15 months follow up was 23 out of 35.
The hair at the treatment area is counted at Baseline and 15 months following the last treatment. Hair clearance is determined by the percentage of Hair left 15 months following the last treatment compared to the hair number at baseline.
Outcome measures
| Measure |
HS Treatment
n=23 Participants
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Hair Count
|
42 percentage of hair clearance
Standard Deviation 25
|
Adverse Events
HS Treatment
Serious adverse events
| Measure |
HS Treatment
n=35 participants at risk
Treatment with the LightSheer Duet laser HS handpiece:
Treatment parameters: Fluence: 9-12J/cm2, pulse duration: 30 to 70ms,medium to low vacuum levels.
All patients were treated in the Axilla area.
|
|---|---|
|
Musculoskeletal and connective tissue disorders
injured ankle
|
2.9%
1/35
|
Other adverse events
Adverse event data not reported
Additional Information
Suzanne Kilmer, MD
Laser & Skin Surgery Medical Group Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place